embecta to Participate in Investor Events
Rhea-AI Summary
embecta (Nasdaq: EMBC) announced that its management will participate in two upcoming investor conferences. At the Wells Fargo 2026 Healthcare Conference, management will hold one-on-one investor meetings on September 9, 2026, at the Encore Boston Harbor Hotel in Everett, Boston, MA. At the J.P. Morgan 4th Annual Nashville Healthcare Conference 2026, management will host a fireside chat on September 10, 2026, at 8:00 a.m. CT, and conduct one-on-one meetings at the Joseph Hotel in Nashville.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PARSIPPANY, N.J., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor events:
Wells Fargo 2026 Healthcare Conference
Management will host one-on-one investor meetings on Wednesday, September 9, 2026, at the Encore Boston Harbor Hotel in Everett, Boston, MA.
J.P. Morgan 4th Annual Nashville Healthcare Conference 2026
Management will host a fireside chat on Thursday, September 10, 2026, at 8:00 a.m. CT, as well as one-on-one investor meetings, at the Joseph Hotel, Nashville.
About embecta
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,500 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
| Contacts: | |
| Media | Investors |
| Christian Glazar | Patricia Gonzalez |
| Sr. Director, Corporate Communications | VP, Corporate FP&A and Investor Relations |
| 908-821-6922 | 862-341-2809 |
| Contact Media Relations | Contact IR |